Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
Contact Us
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
Healthcare for All
Shared Knowledge for a Better Life for All
Heritage
Keys to Aging Gracefully
Shared Knowledge for a Better Life for All
LEARN MORE
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
SDGs
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
How We Drive: Sustainable Value
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
Message from the CEO
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
December 2018
December 18, 2018
12/18/2018
Takeda Announces Listing of American Depository Shares on the New York Stock Exchange
December 14, 2018
12/14/2018
Takeda Receives Positive CHMP Opinion for ADCETRIS®
December 12, 2018
12/12/2018
Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners
December 12, 2018
12/12/2018
GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
December 5, 2018
12/5/2018
Takeda Shareholders Approve Resolutions related to the Proposed Acquisition of Shire plc
December 4, 2018
12/4/2018
Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin)
December 3, 2018
12/3/2018
Takeda Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc
December 2, 2018
12/2/2018
Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
November 2018
November 27, 2018
11/27/2018
European Commission Approves ALUNBRIG® (brigatinib) for ALK+ Non-Small Cell Lung Cancer
1
2
3
4
5
TOP
